Migraine in Adolescents

Status: Recruiting
Location: See location...
Intervention Type: Device, Diagnostic test, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Aim 1. To identify psychophysical and neural factors predicting migraine onset in adolescents Aim 2a. To determine hormonal, psychophysical, and neural changes associated with migraine onset. Aim 2b. To identify the temporal relationships between hormonal, psychophysical, and neural changes preceding vs. following migraine onset. Aim 3. To identify psychophysical and neural factors predicting migraine prognosis in adolescents with migraine.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
Maximum Age: 13
Healthy Volunteers: t
View:

• Age 10-13

• Males or females (biological sex)

• Not diagnosed with migraine or having migraine symptoms

• With a first degree relative diagnosed with migraine (for the Fam-His group) or without a first or a second degree relative diagnosed with migraine (for the No-Fam-His group)

• Age 10-13

• Males or females (biological sex)

• Diagnosed with migraine or having migraine symptoms

• Migraine duration \> 6 months

• Without preventative treatment or with stable preventative treatment for migraine (no change in intervention in the last 6 months)

Locations
United States
Missouri
Washington University School of Medicine
RECRUITING
St Louis
Contact Information
Primary
Alana McMichael, MA
painlab@wustl.edu
314-273-6194
Backup
Hadas Nahman-Averbuch
314-273-6194
Time Frame
Start Date: 2023-06-01
Estimated Completion Date: 2030-03-15
Participants
Target number of participants: 250
Treatments
Other: Family History of Migraine
This group has a first degree relative diagnosed with migraine.
Other: No Family History of Migraine
This group does not have a first or second degree relative diagnosed with migraine.
Related Therapeutic Areas
Sponsors
Leads: Washington University School of Medicine
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)

This content was sourced from clinicaltrials.gov